QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 201 filers reported holding QIAGEN NV in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,161,000 | +1.8% | 41,456 | -0.2% | 0.03% | -3.3% |
| Q3 2016 | $1,141,000 | +25.9% | 41,556 | 0.0% | 0.03% | +25.0% |
| Q2 2016 | $906,000 | -2.4% | 41,556 | 0.0% | 0.02% | -4.0% |
| Q1 2016 | $928,000 | -19.2% | 41,556 | 0.0% | 0.02% | -19.4% |
| Q4 2015 | $1,149,000 | +7.4% | 41,556 | +0.2% | 0.03% | 0.0% |
| Q3 2015 | $1,070,000 | +4.6% | 41,456 | +0.5% | 0.03% | +14.8% |
| Q2 2015 | $1,023,000 | -2.6% | 41,256 | -1.0% | 0.03% | -3.6% |
| Q1 2015 | $1,050,000 | +10.9% | 41,656 | +3.2% | 0.03% | +7.7% |
| Q4 2014 | $947,000 | +3.0% | 40,356 | 0.0% | 0.03% | 0.0% |
| Q3 2014 | $919,000 | -7.1% | 40,356 | -0.2% | 0.03% | -7.1% |
| Q2 2014 | $989,000 | +11.8% | 40,456 | -3.6% | 0.03% | +7.7% |
| Q1 2014 | $885,000 | -10.7% | 41,956 | +0.7% | 0.03% | -10.3% |
| Q4 2013 | $991,000 | +11.2% | 41,656 | 0.0% | 0.03% | 0.0% |
| Q3 2013 | $891,000 | +6.7% | 41,656 | -0.7% | 0.03% | +3.6% |
| Q2 2013 | $835,000 | – | 41,956 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |